“Silymarin”, a Promising Pharmacological Agent for Treatment of Diseases

سال انتشار: 1390
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 234

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-14-4_002

تاریخ نمایه سازی: 3 آبان 1400

چکیده مقاله:

Widespread use of herbal drugs because of their protective effects on different organs toxicity has been shown in many studies. These protective effects have been illustrated in the fields of nephrotoxicity, hepatotoxicity, viral hepatitis, cancer, in vitro fertilization, neurotoxicity, depression, lung diseases, prostate diseases etc. Silymarin has cytoprotection activities due to its antioxidant activity and radical scavenging. The possible known mechanisms of action of silymarin protection are blockade and adjustment of cell transporters, p-glycoprotein, estrogenic and nuclear receptors. Moreover, silymarin anti-inflammatory effects through reduction of TNF-a, protective effects on erythrocyte lysis and cisplatin-induced acute nephrotoxicity have been indicated in some studies. Silymarin has also inhibited apoptosis and follicular development in patients undergoing IVF. Basis on such data, silymarin can be served as a novel medication in complementary medicine.

کلیدواژه ها:

نویسندگان

Gholamreza Karimi

Medical Toxicology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Maryam Vahabzadeh

Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Parisa Lari

Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Marziyeh Rashedinia

Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad Moshiri

Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Kren V, Walterova D. Silybin and Silymarin - New effects ...
  • Dermarderosin A. The review of natural products. ۱st ed. United ...
  • Mayer KE, Mayer RP, Lee SS. Silymarin treatment of viral ...
  • Saller R, Melzer J, Reichling J, Brignoli R, Meier R. ...
  • Cesanow N, Fleminh H, Kelly GA. PDR for nonprescription drugs, ...
  • Kaur M, Agarwal R. Silymarin and epithelial cancer chemoprevention: How ...
  • Karimi G, Ramezani M, Tahoonian Z. Cisplatin nephrotoxicity and protection ...
  • Basiglio CL, Sanchez Pozzi EJ, Mottino AD, Roma MG. Differential ...
  • Gazak R, Walterova D, Kren V. Silybin and silymarin - ...
  • Ramakrishnan G, Lo Muzio L, Elinos-Baez CM, Jagan S, Augustine ...
  • Toklu HZ, Tunali-Akbay T, Erkanli G, Yuksel M, Ercan F, ...
  • Eminzade S, Uraz F, Izzettin FV. Silymarin protects liver against ...
  • Katiyar SK, Roy AM, Baliga MS. Silymarin induces apoptosis primarily ...
  • Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component ...
  • Morishima C , Shuhart MC, Wang CC, Paschal DM, Apodaca ...
  • Song Z, Song M, Lee DYW, Liu Y, Deaciuc IV, ...
  • Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component ...
  • Upadhyay G, Tiwari MN, Prakash O, Jyoti A, Shanker R, ...
  • Polyak SJ, Morishima C, Shuhart MC. Inhibition of T-cell inflammatory ...
  • Ahmed-Belkacem A, Ahnou N, Barbotte L, Wychowski C, Pallier C, ...
  • Miranda SR, Jin KL, Brouwer KLR, Wen Z, Smith PC, ...
  • Pradeep K, Mohan CVR, Gobianand K, Karthikeyan S. Silymarin: An ...
  • Stickel F, Schuppan D. Herbal medicine in the treatment of ...
  • Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, ...
  • Saller R, Meier R, Brignoli R. The use of silymarin ...
  • Tyagi AK , Agarwal C, Chan DC, Agarwal R. Synergistic ...
  • Tyagi A, Agarwal C, Harrison G, Glode L M, Agarwal ...
  • Chu SC, Chiou HL, Chen PN, Yang SF, Hsieh YS. ...
  • Lahiri-Chatterjee M, Katiyar SK, Mohan RR, Agarwal R. A flavonoid ...
  • Deep G, Singh RP, Agarwal C, Kroll DJ , Agarwal ...
  • Thelen P, Jarry H, Ringert RH, Wuttke W. Silybinin down-regulates ...
  • Rana P, Agarwal S, Agarwal R. Prostate cancer chemoprevention by ...
  • Li LH, Wu LJ, Jiang YY, Tashiro S, Onodera S, ...
  • Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. ...
  • Szkudelski T. The mechanism of alloxan and streptozocin action in ...
  • Sha S, Baliga R, Rajapurkar M, Fonseca V. Oxidants in ...
  • Soto C, Mena R, Luna J, Cerbon M, Larrieta E, ...
  • Soto C, Perez J, Garcia V, Uria E, Vadillo M, ...
  • Varzi HN, Esmailzadeh S, Morovvati H, Avizeh R, Shahriari A, ...
  • Karimi G, Ramezani M, Tahoonian Z. Cisplatin nephrotoxicity and protection ...
  • Karimi G, Fallah Huseini H, Ramezani M, Tahoonian Z. Protective ...
  • Kaur G, Athar M, Alam MS. Dietary supplementation of silymarin ...
  • Nazemian F, Karimi GH, Moatamedi M, Charkazi S, Shamsara J, ...
  • Galhardi F, Mesquita K, Monserrat JM, Barros DM. Effect of ...
  • Nencini C, Giorgi G, Micheli L. Protective effect of silymarin ...
  • Davies K J. Oxidative stress, antioxidant defenses, and damage removal, ...
  • Metodiewa D, Koska C. Reactive oxygen species and reactive nitrogen ...
  • Baluchnejadmojarad T, Roghani M, Mafakheri M. Neuroprotective effect of silymarin ...
  • Karimi G, Saradeghi Keisari M. Evaluation of antidepressant effect of ...
  • Gharagozloo M, Velardi E, Bruscoli S, Agostini M, Di Sante ...
  • Soto PC, Sanchez RM, Uria CE, Favari PL. Silymarin effect ...
  • Soto C, Recoba R, Barron H, Alvarez C, Favari L. ...
  • Karimi GH, Hassanzadeh M, Mehri S. Protective effects of Silymarin ...
  • Psotova J, Chlopcikova S, Miketova P, Hrbac J, Simanek V. ...
  • El-Shitany NA, Hegazy S, El-desoky K. Evidences for antiosteoporotic and ...
  • Kiruthiga PV, Pandian SK, Devi KP. Silymarin protects PBMC against ...
  • نمایش کامل مراجع